Experiments are ongoing to investigate the BCL-XL localization at the nucleus in melanoma cells overexpressing BCL-XL and the mechanism of BCL-XL-mediated activation of HIF-1/VEGF axis. The gene discussed is HIF1A; the disease is melanoma.